OrbiMed Advisors LLC's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Jan 26, 2024
- Accession no.
- 0000950170-24-008053
- Filed
- Jan 26, 2024, 7:14 PM ET
- Trade date
- Jan 25, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $7.50M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Israel GP Ltd.CIK 0001569590 | Director, 10% Owner |
| OrbiMed Israel BioFund GP Limited PartnershipCIK 0001569821 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | Director, 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | Director, 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | Common Stock | PPurchaseAcquired | +1,841,100 | $2.40 | +$4,418,640 | 7,526,359 | Indirect | Duplicate filing |
| Jan 25, 2024 | Common Stock | PPurchaseAcquired | +242,200 | $2.40 | +$581,280 | 990,254 | Indirect | Duplicate filing |
| Jan 25, 2024 | Common Stock | PPurchaseAcquired | +1,041,700 | $2.40 | +$2,500,080 | 1,255,985 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.